ClinicalTrials.Veeva

Menu

The Correlation Between the n-6:n-3 Ratio and Inflammatory Markers in Small for Gestational Age (SGA) Infants Compared With Appropriate for Gestational Age (AGA) Infants

T

Tel Aviv Sourasky Medical Center

Status

Unknown

Conditions

Appropriate for Gestational Age Infants
Small for Gestational Age Infants

Treatments

Procedure: Blood test

Study type

Observational

Funder types

Other

Identifiers

NCT02887664
0285-16-TLV-DM

Details and patient eligibility

About

Numerous studies have recommended the use of n-3 PUFA supplementation during human pregnancy and lactation for the prevention of preterm birth, beneficial effects on fetal development, visual and cognitive development and other functional outcomes of the infants.

The aim of the present study is to assess the correlation between ratio of n-3:n-6 fatty acid and inflammation markers in SGA infants compared with appropriate for gestational age (AGA) infants. The investigators hypothesize that in SGA infants n-3 and n-6 fatty acid concentrations in cord blood will differ from those observed in AGA and might correlate with the level of circulating mediators.

Enrollment

60 estimated patients

Sex

Female

Ages

18 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Mothers of SGA infants ( above 35 week of gestation)
  • Mothers of term and near-term AGA infants

Exclusion criteria

  • Maternal chronic diseases, smoking, diabetes, alcohol use, pregnancy-associated hypertension and pre-eclampsia
  • Neonatal depression
  • Congenital malformations
  • Intrauterine infections
  • Chromosomal aberrations
  • Mothers interested in cord blood banking

Trial design

60 participants in 2 patient groups

Blood test in Mothers of SGA Infants
Description:
In mothers of Small for Gestational Age (SGA) Infants, maternal and cord blood test will be performed
Treatment:
Procedure: Blood test
Blood test in Mothers of AGA infants
Description:
In mothers of Appropriate for Gestational Age (AGA) Infants, maternal and cord blood test will be performed
Treatment:
Procedure: Blood test

Trial contacts and locations

1

Loading...

Central trial contact

Dror Mandel, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems